Foghorn Therapeutics Inc.Foghorn Therapeutics Inc.Foghorn Therapeutics Inc.

Foghorn Therapeutics Inc.

No trades
See on Supercharts

Price target

17.400.000.00%
The 5 analysts offering 1 year price forecasts for FHTX have a max estimate of — and a min estimate of —.

Analyst rating

Based on 6 analysts giving stock ratings to FHTX in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


FHTX EPS for the last quarter is −0.45 USD despite the estimation of −0.64 USD. In the next quarter EPS is expected to reach −0.43 USD. Track more of Foghorn Therapeutics Inc. financials and stay on top of what is up with the company.
In the next quarter Foghorn Therapeutics Inc. revenue is expected to reach ‪6.34 M‬ USD. Check out Foghorn Therapeutics Inc. revenue and earnings and make informed decisions.
According to analysts, FHTX price target is 17.40 USD with a max estimate of 20.00 USD and a min estimate of 13.00 USD. Check if this forecast comes true in a year, meanwhile watch Foghorn Therapeutics Inc. stock price chart and keep track of the current situation with FHTX news and stock market news.
We've gathered opinions of 6 analysts rating FHTX stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.